FMI
REGN icon

F/M Investments’s Regeneron Pharmaceuticals REGN Stock Holding History

F/M Investments’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.5M Sell
16,783
-601
-3% -$409K 0.53% 38
2026
Q1 		$13.4M Sell
17,384
-5,429
-24% -$4.16M 0.89% 27
2025
Q4 		$17.6M Buy
22,813
+16,270
+249% +$11M 0.67% 27
2025
Q3 		$3.68M Sell
6,543
-145
-2% -$82K 0.14% 172
2025
Q2 		$3.51M Buy
6,688
+89
+1% +$49.7K 0.13% 175
2025
Q1 		$4.19M Sell
6,599
-404
-6% -$278K 0.17% 137
2024
Q4 		$4.99M Buy
7,003
+550
+9% +$462K 0.18% 114
2024
Q3 		$6.78M Sell
6,453
-255
-4% -$284K 0.21% 149
2024
Q2 		$7.05M Buy
+6,708
New +$6.5M 0.25% 130
2022
Q3 		– Sell
-4,537
Closed -$2.53M – 73
2022
Q2 		$2.53M Buy
+4,537
New +$2.95M 2% 16
2021
Q4 		– Sell
-4,549
Closed -$2.75M – 95
2021
Q3 		$2.75M Buy
4,549
+12
+0.3% +$7.45K 1.97% 14
2021
Q2 		$2.53M Buy
+4,537
New +$2.3M 2% 16

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

F/M Investments's REGN Position: Q2 2026 in Review

F/M Investments reduced its Regeneron Pharmaceuticals (REGN) stake by 3.5% in Q2 2026, selling an estimated $409K and leaving 16,783 shares worth $10.5M. The position accounts for 0.53% of the portfolio, ranked #38.

F/M Investments first reported a position in REGN in Q2 2021 and has held it in 12 quarters since. The position peaked at $17.6M in Q4 2025. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • F/M Investments held 16,783 shares of Regeneron Pharmaceuticals worth $10.5M as of Q2 2026.
  • F/M Investments sold 601 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $409K.
  • Regeneron Pharmaceuticals made up 0.53% of F/M Investments's portfolio in Q2 2026, its #38 holding.
  • F/M Investments first reported a position in Regeneron Pharmaceuticals in Q2 2021 and has held it in 12 quarters since.
  • F/M Investments's Regeneron Pharmaceuticals position peaked at $17.6M in Q4 2025.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on F/M Investments's 13F filing for Q2 2026, filed 5 Aug 2026.